Farid Menaa (B.Sc. Eng., B.Sc. Bio., M.Sc. Genetics, Master Gerontology/Geriatry, Ph.D. Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. He is a Professor, principal investigator, Director, consultant editor, reviewer, event organizer, and entrepreneur. He earned his degrees with highest distinctions from prestigious French universities and institutions. He followed a post-doctoral in oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, he pursued his career in dermatology, and stem cells as a DFG-Fellow (Wuerzburg, Germany; 2007-2009). Then, he was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, he was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010-2012). He authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). He is often invited as a speaker; keynote/featured speaker and (co-) chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences, and technology

His research interest mainly focuses in related to preventive, personalized, translational, and integrative, nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy